Harry Fisch

This inventor holds 11 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Aspen Park Pharmaceuticals, Inc., Millennium Sciences, Other. Active years: 1994-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Harry Fisch. Retrieved from https://idiyas.com/inventor/harry-fisch

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 2)

% Patents Active = 90.9

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 1.2

ph-index = 7

Forward Citations = 250(Granted Patents)

Location History:

Bronx, NY (US) (1994)
Scarsdale, NY (US) (1999 - 2020)

Company Filing History:

3 out of 3

Aspen Park Pharmaceuticals, Inc.

3 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 1994-2020

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10758500 - Treating androgen deprivation therapy induced hot flashes and bone loss in men using cis-clomiphene (2020-09-01),

2. 10463635 - Treating androgen deprivation therapy induced hot flashes and bone loss in men using cis-clomiphene (2019-11-05),

3. 9913815 - Treating androgen deprivation therapy induced hot flashes and bone loss in men using cis-clomiphene (2018-03-13),

4. D569990 - Microscope slide assembly (2008-05-27),

5. 7067557 - Methods of treating androgen deficiency in men using selective antiestrogens (2006-06-27),

6. 6391920 - Methods of treating androgen deficiency in men using selective antiestrogens (2002-05-21),

7. D431301 - Microscope slide assembly (2000-09-26),

8. D431300 - Microscope slide assembly (2000-09-26),

9. D423678 - Microscope slide assembly (2000-04-25),

10. D418228 - Microscope slide assembly (1999-12-28),

11. 5349436 - Biological assembly (1994-09-20),

Title: The Innovative Journey of Harry Fisch in Medicine

Introduction

Harry Fisch, located in Scarsdale, NY, is a prominent inventor with a strong focus on medical innovations. With a remarkable portfolio of 11 patents, Fisch has dedicated his career to advancing the treatment of conditions related to prostate cancer. His inventions have significantly contributed to improving the quality of life for many patients suffering from androgen deprivation therapy effects.

Latest Patents

Among Harry Fisch's notable inventions is his recent patent addressing androgen deprivation therapy-induced hot flashes and bone loss in men. This invention outlines several critical methods for treating and preventing osteoporotic conditions in male patients suffering from prostate cancer. The patent details a pharmaceutical composition comprising cis-clomiphene, which serves multiple purposes, including:

1. A method of treating androgen-deprivation induced osteoporosis, bone fractures, loss of bone mineral density (BMD), and/or hot flashes in males.

2. A method of preventing these conditions in male subjects undergoing prostate cancer treatment.

3. A method for suppressing or inhibiting the associated adverse effects linked to androgen deprivation therapy.

4. A method to reduce the risk of developing osteoporosis and bone-related issues by administering effective doses of cis-clomiphene or its pharmaceutically acceptable salts.

Career Highlights

Harry Fisch has made significant strides in the medical field through his innovative inventions. He has played key roles in companies such as Aspen Park Pharmaceuticals, where he has worked extensively to develop treatments that cater to specific medical conditions. His dedication to research and development has led to advancements that not only enhance patient care but also foster greater understanding of treatment options available for prostate cancer.

Collaborations

Throughout his career, Fisch has collaborated with esteemed professionals in the industry. One notable partnership is with Mitchell S. Steiner, a prominent figure in the medical research community. Their joint efforts have led to the exploration of new therapeutic approaches, further highlighting Fisch's commitment to advancing healthcare solutions.

Conclusion

Harry Fisch's innovative contributions to medical science, particularly in treating conditions related to prostate cancer, underscore his role as a leading inventor. His extensive portfolio of patents and collaborations with fellow researchers reflect his dedication to improving patient outcomes and advancing medical treatments. Fisch's work continues to inspire and pave the way for new innovations in the healthcare industry.

Profile summary based on public USPTO records.